Cancio-Suárez, M.R.; Díaz-Álvarez, J.; Ron, R.; Martínez-Sanz, J.; Serrano-Villar, S.; Moreno, S.; Sánchez-Conde, M. From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications. Pathogens2023, 12, 924.
Cancio-Suárez, M.R.; Díaz-Álvarez, J.; Ron, R.; Martínez-Sanz, J.; Serrano-Villar, S.; Moreno, S.; Sánchez-Conde, M. From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications. Pathogens 2023, 12, 924.
Cancio-Suárez, M.R.; Díaz-Álvarez, J.; Ron, R.; Martínez-Sanz, J.; Serrano-Villar, S.; Moreno, S.; Sánchez-Conde, M. From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications. Pathogens2023, 12, 924.
Cancio-Suárez, M.R.; Díaz-Álvarez, J.; Ron, R.; Martínez-Sanz, J.; Serrano-Villar, S.; Moreno, S.; Sánchez-Conde, M. From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications. Pathogens 2023, 12, 924.
Abstract
Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention strategy that involves the continuous administration of antiretroviral drugs to HIV-negative individuals wit a substantial risk of contracting an HIV infection. The use of PrEP has shown a reduction in the risk of HIV acquisition through sexual intercourse by up to 99%. Despite its effectiveness, PrEP uptake remains low among populations at high risk of HIV infection. This highlights the need for further research in stratetegies to enhance awareness and uptake of PrEP amongst these specific populations
Medicine and Pharmacology, Epidemiology and Infectious Diseases
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
